The abstract is read at the publisher; the summary is JClub's.
A unified asymmetric total synthesis delivers (-)-ganocins A-C and (+)-cochlearol B using a non-biomimetic route with diastereoselective oxa-Michael addition and SmI2-mediated 4-exo-trig coupling.
- Why it matters: Distinct meroterpenoid skeletons drive three-dimensional diversity that supports drug discovery, yet a single asymmetric strategy for these four Ganoderma targets has remained elusive.
- What they did: The approach combines diastereoselective oxa-Michael addition with acid-controlled divergent cascade aldol/etherification cyclization or aldol/dehydration, followed by SmI2-mediated 4-exo-trig reductive cross-coupling.
- The result: The reported synthesis provides a general solution to an intractable problem for biomimetic approaches, enabling rapid access to these distinct molecular skeletons.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.